Management Change/Compensation (Form 8-K)

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

​

As previously disclosed in a Current Report on Form 8-K filed by Zynex, Inc. (the "Company") with the Securities and Exchange Commission on October 14, 2025, Anna Lucsok resigned from her position as Chief Commercial Officer of the Company, effective as of October 10, 2025, at which time Ms. Lucsok was placed on paid leave during the pendency of the negotiation of the terms of her separation, which were finalized on October 27, 2025 (the "Separation Date").

​

In connection with her resignation, Ms. Lucsok is entitled to receive the severance payments and benefits set forth in her Employment Agreement with the Company, dated January 27, 2021 (the "Lucsok Employment Agreement"), as described in the Proxy Statement under the heading "Compensation Agreements" and "Payments Made Upon Termination," subject to and conditioned upon Ms. Lucsok's execution, non-revocation and continued compliance with the terms of the Separation Agreement and Release of Claims that Ms. Lucsok entered into with the Company, dated October 27, 2025 (the "Lucsok Separation Agreement").

​

In addition, on October 20, 2025, the Compensation Committee of the Company's Board of Directors approved the accelerated vesting of 60,746 unvested restricted shares of the Company's common stock previously issued to Ms. Lucsok under the Company's 2017 Stock Option Plan and award agreements thereunder, effective as of the Separation Date and subject to the same conditions as Ms. Lucsok's receipt of severance benefits under the Lucsok Employment Agreement.

​

​

​

​